Results 271 to 280 of about 339,433 (382)

Proceedings of the International creatine conference 2025 - Munich, Germany. [PDF]

open access: yesJ Int Soc Sports Nutr
Bonilla DA, Stout JR, Kreider RB.
europepmc   +1 more source

Single and dual RPA‐CRISPR/Cas assays for point‐of‐need detection of Stewart's wilt pathogen (Pantoea stewartii subsp. stewartii) of corn and Maize dwarf mosaic virus

open access: yesPest Management Science, Volume 81, Issue 4, Page 1988-1999, April 2025.
Schematic diagram of the single and dual RPA‐CRISPR/Cas12a/13a diagnostic assays for the detection of Pantoea stewartii subsp. stewartii and Maize dwarf mosaic virus. The validated assays provide a useful and sensitive molecular tool for detecting two quarantine pathogens of maize within a minimal resource framework suitable for fast‐tracking the ...
Qian Tian   +6 more
wiley   +1 more source

Clinical modeling of motor function to predict treatment efficacy and enable in silico treatment comparisons in infantile‐onset Pompe disease

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
Abstract Infantile‐onset Pompe disease (IOPD) is a rare, deadly, quickly‐progressing degenerative disease. Even with life‐sustaining treatment (e.g., alglucosidase alfa [ALGLU]), many patients experience continued motor impairment. The Mini‐COMET trial evaluated avalglucosidase alfa (AVAL) versus ALGLU on motor and other outcomes in IOPD.
Fatiha Rachedi   +6 more
wiley   +1 more source

Resistance of mature and elderly bodybuilders to anaerobic energy supply load. [PDF]

open access: yesPeerJ
Chernozub A   +8 more
europepmc   +1 more source

Approach to asymptomatic creatine kinase elevation

open access: yesCleveland Clinic journal of medicine, 2016
S. Moghadam-Kia, C. Oddis, R. Aggarwal
semanticscholar   +1 more source

Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B Patients

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pegbing (peginterferon alpha‐2b) is a polyethylene glycol‐modified interferon α‐2b injection that has demonstrated favorable efficacy and safety profiles in the treatment of chronic hepatitis B (CHB). This study aimed to develop a population pharmacokinetic (PopPK) model of Pegbing in both healthy subjects and CHB patients and to investigate ...
Weizhe Jian   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy